Platinum Equity-backed Peli BioThermal completed the acquisition of the cold chain logistics subsidiary of BioLife Solutions for $25.5m.

Platinum Equity-backed Peli BioThermal, a temperature-controlled logistics solutions provider, completed the acquisition of the cold chain logistics subsidiary of BioLife Solutions, a developer and supplier of cell processing tools for the cell and gene therapy market, for $25.5m. "This divestiture streamlines our product portfolio as well as our operations while focusing resources on creating shareholder value through high-margin recurring revenue. We are delighted that a respected leader in cold chain logistics recognizes the value of the SAVSU evo technology," Roderick de Greef, BioLife Solutions Chairman and CEO.